Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.
about
Octreotide-periplocymarin conjugate prodrug for improving targetability and anti-tumor efficiency: synthesis, in vitro and in vivo evaluation.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Octreotide-periplocymarin conj ...... vitro and in vivo evaluation.
@en
Octreotide-periplocymarin conj ...... vitro and in vivo evaluation.
@nl
type
label
Octreotide-periplocymarin conj ...... vitro and in vivo evaluation.
@en
Octreotide-periplocymarin conj ...... vitro and in vivo evaluation.
@nl
prefLabel
Octreotide-periplocymarin conj ...... vitro and in vivo evaluation.
@en
Octreotide-periplocymarin conj ...... vitro and in vivo evaluation.
@nl
P2093
P2860
P356
P1433
P1476
Octreotide-periplocymarin conj ...... vitro and in vivo evaluation.
@en
P2093
Emmanuel Omari-Siaw
Hui-Yun Zhang
Jiang-Nan Yu
Shan-Shan Tong
Wen-Qian Xu
Xi-Ming Xu
Yuan-Yuan Zheng
P2860
P304
86326-86338
P356
10.18632/ONCOTARGET.13389
P407
P577
2016-11-16T00:00:00Z